Omega Interest Expense vs Total Revenue Analysis
OHI Stock | USD 30.63 0.05 0.16% |
Omega Healthcare financial indicator trend analysis is much more than just breaking down Omega Healthcare Inv prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omega Healthcare Inv is a good investment. Please check the relationship between Omega Healthcare Interest Expense and its Total Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Interest Expense vs Total Revenue
Interest Expense vs Total Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omega Healthcare Inv Interest Expense account and Total Revenue. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Omega Healthcare's Interest Expense and Total Revenue is 0.98. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Omega Healthcare Investors, assuming nothing else is changed. The correlation between historical values of Omega Healthcare's Interest Expense and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Omega Healthcare Investors are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Interest Expense i.e., Omega Healthcare's Interest Expense and Total Revenue go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts Omega Healthcare Inv generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most indicators from Omega Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omega Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. As of now, Omega Healthcare's Selling General Administrative is increasing as compared to previous years. The Omega Healthcare's current Tax Provision is estimated to increase to about 3.4 M, while Issuance Of Capital Stock is projected to decrease to under 228.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.0B | 861.3M | 934.7M | 981.5M | Total Revenue | 1.1B | 878.2M | 949.7M | 997.2M |
Omega Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Omega Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omega Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.8B | 9.5B | 9.6B | 9.4B | 9.1B | 9.6B | |
Short Long Term Debt Total | 5.1B | 5.2B | 5.3B | 5.3B | 5.1B | 5.3B | |
Other Current Liab | 312.0M | 280.8M | 268.4M | 315.0M | 287.8M | 302.2M | |
Total Current Liabilities | 437.0M | 382.0M | 268.5M | 334.3M | 308.2M | 234.0M | |
Total Stockholder Equity | 4.1B | 3.8B | 3.9B | 3.6B | 3.6B | 3.8B | |
Property Plant And Equipment Net | (11.4M) | (10.8M) | (8.2M) | 17.8M | 30.2M | 28.7M | |
Net Debt | 5.1B | 5.0B | 5.2B | 5.0B | 4.6B | 4.9B | |
Retained Earnings | (1.8B) | (2.3B) | (2.5B) | (2.7B) | (3.2B) | (3.0B) | |
Non Current Assets Total | 8.6B | 8.1B | 8.2B | 7.6B | 6.9B | 7.2B | |
Non Currrent Assets Other | 7.3B | 6.8B | 6.9B | 6.8B | 6.0B | 6.3B | |
Other Assets | 830.5M | 7.8B | 7.4B | 6.9B | 6.0B | 6.3B | |
Net Receivables | 1.2B | 1.1B | 1.1B | 1.5B | 1.7B | 1.8B | |
Common Stock Shares Outstanding | 222.1M | 235.1M | 244.3M | 244.3M | 250.5M | 263.0M | |
Liabilities And Stockholders Equity | 9.8B | 9.5B | 9.6B | 9.4B | 9.1B | 9.6B | |
Non Current Liabilities Total | 5.0B | 5.1B | 5.3B | 5.3B | 5.0B | 5.3B | |
Other Stockholder Equity | 6.0B | 6.2B | 6.4B | 6.3B | 3.5B | 2.3B | |
Total Liab | 5.5B | 5.5B | 5.5B | 5.6B | 5.4B | 5.6B | |
Total Current Assets | 1.2B | 1.4B | 1.4B | 1.8B | 2.3B | 2.4B | |
Short Term Debt | 125M | 101.2M | 96K | 19.2M | 20.4M | 19.4M | |
Intangible Assets | 28.0M | 1.9M | 1.6M | 1.4M | 682K | 647.9K | |
Common Stock | 22.7M | 23.1M | 23.9M | 23.4M | 24.5M | 12.3M | |
Accumulated Other Comprehensive Income | (39.9M) | (12.8M) | (2.2M) | 20.3M | 29.3M | 30.8M | |
Other Liab | 71.5M | 10.8M | 8.2M | 21.8M | 25.1M | 23.9M | |
Cash | 24.1M | 163.5M | 20.5M | 297.1M | 442.8M | 465.0M | |
Long Term Debt | 389.7M | 369.5M | 5.3B | 5.3B | 5.0B | 5.3B | |
Cash And Short Term Investments | 24.1M | 163.5M | 20.5M | 297.1M | 442.8M | 465.0M | |
Property Plant Equipment | 7.2B | 6.7B | 6.8B | 6.5B | 7.5B | 7.9B | |
Common Stock Total Equity | 22.7M | 23.1M | 23.9M | 23.4M | 26.9M | 14.5M | |
Other Current Assets | (441.6M) | (412.6M) | (287.5M) | (486.7M) | (671.3M) | (637.7M) | |
Net Tangible Assets | 3.5B | 3.2B | 3.3B | 3.0B | 3.4B | 2.6B | |
Noncontrolling Interest In Consolidated Entity | 201.2M | 194.7M | 201.4M | 193.9M | 223.0M | 182.8M | |
Accounts Payable | 5.1B | 280.8M | 268.5M | 315.0M | 362.3M | 664.3M | |
Good Will | 644.4M | 651.7M | 651.4M | 643.2M | 643.9M | 456.7M | |
Retained Earnings Total Equity | (1.8B) | (2.3B) | (2.5B) | (2.7B) | (2.5B) | (2.4B) | |
Long Term Debt Total | 389.7M | 369.5M | 5.3B | 5.3B | 6.1B | 6.4B | |
Capital Surpluse | 6.0B | 6.2B | 6.4B | 6.3B | 7.3B | 4.5B |
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Omega Healthcare Inv information on this page should be used as a complementary analysis to other Omega Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Omega Stock analysis
When running Omega Healthcare's price analysis, check to measure Omega Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Healthcare is operating at the current time. Most of Omega Healthcare's value examination focuses on studying past and present price action to predict the probability of Omega Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Healthcare's price. Additionally, you may evaluate how the addition of Omega Healthcare to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Omega Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.773 | Dividend Share 2.68 | Earnings Share 1.12 | Revenue Per Share 4.007 | Quarterly Revenue Growth 0.115 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.